{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:24:43Z","timestamp":1789050283911,"version":"build-2803163510"},"reference-count":131,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Key R&D Projects of Science and Technology Department of Sichuan Province","award":["2023YFS0080"],"award-info":[{"award-number":["2023YFS0080"]}]},{"name":"The Health Care Promotion Institute","award":["KY2022SJ0035"],"award-info":[{"award-number":["KY2022SJ0035"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Epileptologica"],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The kynurenine pathway (KP) is the main route for tryptophan (TRP) degradation and plays a crucial role in neuroinflammation, oxidative stress and neurotransmission, which holds significant clinical significance. The dysregulation of this pathway is closely related to neurological disorders such as epilepsy, and its metabolic products can promote the occurrence of epileptic seizures and comorbid depression. This review aims to clarify the complex mechanisms of the KP in the occurrence and development of epilepsy and to explore its potential as a therapeutic target for epilepsy and comorbid depression. This is a narrative review and synthesis of the current literature. We reviewed animal experiments and clinical studies, elaborating in detail on how metabolites of the KP and their key enzymes function in the context of epilepsy by regulating neuroinflammation, oxidative stress, glutamatergic signaling, and the gut-brain axis. We also explored the interaction between antiseizure medications (ASMs) and the KP, and evaluated the potential value of targeting key enzymes (such as indoleamine 2,3-dioxygenase, IDO) as a new therapeutic strategy for epilepsy. This review particularly focuses on the promoting effect of KP imbalance on comorbid depression, clarifying how IDO-mediated TRP metabolism changes constitute a common mechanism basis, jointly leading to the occurrence of epilepsy and depression-like behaviors. The occurrence and development of epilepsy are closely related to the imbalance of the KP, specifically manifested as a decrease in kynurenic acid (KYNA) level and an increase in quinolinic acid (QA) level. The IDO-mediated shift of TRP metabolism towards the KP is established as a critical mechanism underlying depression comorbidity in epilepsy. Therapeutic modulation of this pathway, through targeting key enzymes like IDO and restoring the KYNA\/QA balance, presents a viable strategy for improving the cerebral microenvironment. This approach holds promise for enhancing seizure control, counteracting drug resistance, and concurrently alleviating comorbid depressive symptoms.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s42494-026-00250-w","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:04:49Z","timestamp":1777590289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The kynurenine pathway storm in epilepsy: mechanisms and therapeutic implications"],"prefix":"10.1186","volume":"8","author":[{"given":"Yuxuan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"250_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-023-01700-3","volume":"25","author":"M Leonardi","year":"2024","unstructured":"Leonardi M, Martelletti P, Burstein R, Fornari A, Grazzi L, Guekht A, et al. The World Health Organization intersectoral global action plan on epilepsy and other neurological disorders and the headache revolution: from headache burden to a global action plan for headache disorders. J Headache Pain. 2024;25:4.","journal-title":"J Headache Pain"},{"key":"250_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108394","volume":"125","author":"H Rashid","year":"2021","unstructured":"Rashid H, Upadhyay AD, Pandey RM, Katyal J. Point prevalence of depression in persons with active epilepsy and impact of methodological moderators: a systematic review and meta-analysis. Epilepsy Behav. 2021;125:108394.\u00a0","journal-title":"Epilepsy Behav"},{"key":"250_CR3","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(21)00247-6","volume":"397","author":"A Marson","year":"2021","unstructured":"Marson A, Burnside G, Appleton R, Smith D, Leach JP, Sills G, et al. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021;397:1363\u201374.\u00a0","journal-title":"Lancet"},{"key":"250_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11064-005-2678-0","volume":"30","author":"RG Tavares","year":"2005","unstructured":"Tavares RG, Schmidt AP, Abud J, Tasca CI, Souza DO. In vivo quinolinic acid increases synaptosomal glutamate release in rats: reversal by guanosine. Neurochem Res. 2005;30:439\u201344.\u00a0","journal-title":"Neurochem Res"},{"key":"250_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1179\/135100004225006001","volume":"9","author":"F St\u2019astn\u00fd","year":"2004","unstructured":"St\u2019astn\u00fd F, Lis\u00fd V, Mares V, Lis\u00e1 V, Balcar VJ, Santamar\u00eda A. Quinolinic acid induces NMDA receptor-mediated lipid peroxidation in rat brain microvessels. Redox Rep Commun Free Radical Res. 2004;9:229\u201333.","journal-title":"Redox Rep Commun Free Radical Res"},{"key":"250_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ph15070882","volume":"15","author":"E Bettini","year":"2022","unstructured":"Bettini E, De Martin S, Mattarei A, Pappagallo M, Stahl SM, Bifari F, et al. The N-methyl-D-aspartate receptor blocker REL-1017 (esmethadone) reduces calcium influx induced by glutamate, quinolinic acid, and gentamicin. Pharmaceuticals (Basel). 2022;15:882.\u00a0","journal-title":"Pharmaceuticals (Basel)"},{"key":"250_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1644783","volume":"16","author":"AM Kezai","year":"2025","unstructured":"Kezai AM, Badiane PY, Hennart B, Allorge D, Marion S, H\u00e9bert SS. MicroRNA-132 regulates quinolinic acid production in the brain during LPS-induced neuroinflammation. Front Immunol. 2025;16:1644783.\u00a0","journal-title":"Front Immunol"},{"key":"250_CR8","doi-asserted-by":"publisher","first-page":"10799","DOI":"10.1007\/s00210-025-03976-5","volume":"398","author":"F Goel","year":"2025","unstructured":"Goel F, Dobhal V, Singh S. Protective effects of diacerein against quinolinic acid-induced Huntington\u2019s disease-like symptoms in adult zebrafish by targeting GSK-3\u03b2 signalling. Naunyn Schmiedebergs Arch Pharmacol. 2025;398:10799\u2013821.\u00a0","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"250_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031300","volume":"22","author":"Y-C Lo","year":"2021","unstructured":"Lo Y-C, Lin C-L, Fang W-Y, L\u0151rinczi B, Szatm\u00e1ri I, Chang W-H, et al. Effective activation by kynurenic acid and its aminoalkylated derivatives on M-type K+ current. Int J Mol Sci. 2021;22:1300.\u00a0","journal-title":"Int J Mol Sci"},{"key":"250_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70381","volume":"31","author":"C Wu","year":"2025","unstructured":"Wu C, Diao M, Yu S, Xi S, Zheng Z, Cao Y, et al. Gut microbial tryptophan metabolism is involved in post-cardiac arrest brain injury via pyroptosis modulation. CNS Neurosci Ther. 2025;31:e70381.\u00a0","journal-title":"CNS Neurosci Ther"},{"key":"250_CR11","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1080\/14728222.2023.2277863","volume":"27","author":"M Dhureja","year":"2023","unstructured":"Dhureja M, Arthur R, Soni D, Upadhayay S, Temgire P, Kumar P. Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA. Expert Opin Ther Targets. 2023;27:1159\u201372.\u00a0","journal-title":"Expert Opin Ther Targets"},{"key":"250_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2024.1454780","volume":"17","author":"W Yang","year":"2024","unstructured":"Yang W, Cui H, Wang C, Wang X, Yan C, Cheng W. A review of the pathogenesis of epilepsy based on the microbiota-gut-brain-axis theory. Front Mol Neurosci. 2024;17:1454780.\u00a0","journal-title":"Front Mol Neurosci"},{"key":"250_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12916-025-04425-z","volume":"23","author":"M Sarangdhar","year":"2025","unstructured":"Sarangdhar M, Akel S, Hosseini Ashtiani S, Axelsson M, Zelano J. Association between pro-inflammatory proteins and neurofilament in plasma from persons with epilepsy. BMC Med. 2025;23:554.\u00a0","journal-title":"BMC Med"},{"key":"250_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-023-02714-z","volume":"20","author":"M Tassan Mazzocco","year":"2023","unstructured":"Tassan Mazzocco M, Murtaj V, Martins D, Schellino R, Coliva A, Toninelli E, et al. Exploring the neuroprotective effects of montelukast on brain inflammation and metabolism in a rat model of quinolinic acid-induced striatal neurotoxicity. J Neuroinflammation. 2023;20:34.\u00a0","journal-title":"J Neuroinflammation"},{"key":"250_CR15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s12640-022-00484-9","volume":"40","author":"FS Ferreira","year":"2022","unstructured":"Ferreira FS, Dos Santos TM, Ramires Junior OV, Silveira JS, Schmitz F, Wyse ATS. Quinolinic acid impairs redox homeostasis, bioenergetic, and cell signaling in rat striatum slices: prevention by coenzyme Q10. Neurotox Res. 2022;40:473\u201384.\u00a0","journal-title":"Neurotox Res"},{"key":"250_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156944","volume":"145","author":"Y Cao","year":"2025","unstructured":"Cao Y, Zhao K, Zhao Y, Ni Y, Zhang Z, Yuan X, et al. Arbutin ameliorated depression by inhibiting neuroinflammation and modulating intestinal flora. Phytomedicine. 2025;145:156944.\u00a0","journal-title":"Phytomedicine"},{"key":"250_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119518","volume":"344","author":"JMD Santos","year":"2025","unstructured":"Santos JMD, Touguinha L, Bridi R, Andreazza AC, Bick DLU, Davidson CB, et al. Could the inhibition of systemic NLRP3 inflammasome mediate central redox effects of yerba mate? An in silico and pre-clinical translational approach. J Ethnopharmacol. 2025;344:119518.\u00a0","journal-title":"J Ethnopharmacol"},{"key":"250_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.988716","volume":"13","author":"B Miziak","year":"2022","unstructured":"Miziak B, Czuczwar SJ, Pluta R. Comorbid epilepsy and depression-pharmacokinetic and pharmacodynamic drug interactions. Front Pharmacol. 2022;13:988716.\u00a0","journal-title":"Front Pharmacol"},{"key":"250_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3390\/cimb47090764","volume":"47","author":"J Xu","year":"2025","unstructured":"Xu J, Wei L, Fu J, Kong Z, Cai L. IDO activation affects BDNF\/TrkB signaling pathway, oxidative stress, and mitochondrial enzymatic activities in temporal lobe epilepsy. Curr Issues Mol Biol. 2025;47:764.\u00a0","journal-title":"Curr Issues Mol Biol"},{"key":"250_CR20","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/brainsci14090950","volume":"14","author":"EM Cort\u00e9s Malag\u00f3n","year":"2024","unstructured":"Cort\u00e9s Malag\u00f3n EM, L\u00f3pez Ornelas A, Olvera G\u00f3mez I, Bonilla Delgado J. The kynurenine pathway, aryl hydrocarbon receptor, and Alzheimer\u2019s disease. Brain Sci. 2024;14:950.\u00a0","journal-title":"Brain Sci"},{"key":"250_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020;25:131\u201347.\u00a0","journal-title":"Mol Psychiatry"},{"key":"250_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00485","volume":"5","author":"HJ Ball","year":"2014","unstructured":"Ball HJ, Jusof FF, Bakmiwewa SM, Hunt NH, Yuasa HJ. Tryptophan-catabolizing enzymes - party of three. Front Immunol. 2014;5:485.\u00a0","journal-title":"Front Immunol"},{"key":"250_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.136965","volume":"486","author":"SS Kim","year":"2025","unstructured":"Kim SS, Kim S, Kim Y, Ha Y, Lee H, Im H, et al. Neurotoxic effects of citronellol induced by the conversion of kynurenine to 3-hydroxykynurenine. J Hazard Mater. 2025;486:136965.\u00a0","journal-title":"J Hazard Mater"},{"key":"250_CR24","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuro.2012.11.007","volume":"34","author":"AL Col\u00edn-Gonz\u00e1lez","year":"2013","unstructured":"Col\u00edn-Gonz\u00e1lez AL, Maldonado PD, Santamar\u00eda A. 3-hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system. Neurotoxicology. 2013;34:189\u2013204.\u00a0","journal-title":"Neurotoxicology"},{"key":"250_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neuro.2015.08.003","volume":"50","author":"J Reyes-Ocampo","year":"2015","unstructured":"Reyes-Ocampo J, Ram\u00edrez-Ortega D, Cervantes GIV, Pineda B, Balderas PMdeO, Gonz\u00e1lez-Esquivel D, et al. Mitochondrial dysfunction related to cell damage induced by 3-hydroxykynurenine and 3-hydroxyanthranilic acid: non-dependent-effect of early reactive oxygen species production. Neurotoxicology. 2015;50:81\u201391.\u00a0","journal-title":"Neurotoxicology"},{"issue":"Suppl 5","key":"250_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1528-1167.2005.01008.x","volume":"46","author":"J Arbatova","year":"2005","unstructured":"Arbatova J, D\u2019Amato E, Vaarmann A, Zharkovsky A, Reeben M. Reduced serotonin and 3-hydroxyanthranilic acid levels in serum of cystatin B-deficient mice, a model system for progressive myoclonus epilepsy. Epilepsia. 2005;46(Suppl 5):49\u201351.\u00a0","journal-title":"Epilepsia"},{"key":"250_CR27","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.celrep.2018.09.091","volume":"25","author":"L Palzer","year":"2018","unstructured":"Palzer L, Bader JJ, Angel F, Witzel M, Blaser S, McNeil A, et al. Alpha-amino-beta-carboxy-muconate-semialdehyde decarboxylase controls dietary niacin requirements for NAD+ synthesis. Cell Rep. 2018;25:1359-1370.e4.\u00a0","journal-title":"Cell Rep"},{"key":"250_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0014-4886(84)90001-3","volume":"84","author":"R Schwarcz","year":"1984","unstructured":"Schwarcz R, Brush GS, Foster AC, French ED. Seizure activity and lesions after intrahippocampal quinolinic acid injection. Exp Neurol. 1984;84:1\u201317.\u00a0","journal-title":"Exp Neurol"},{"key":"250_CR29","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s00018-009-0166-4","volume":"67","author":"Q Han","year":"2010","unstructured":"Han Q, Cai T, Tagle DA, Li J. Structure, expression, and function of kynurenine aminotransferases in human and rodent brains. Cell Mol Life Sci. 2010;67:353\u201368.\u00a0","journal-title":"Cell Mol Life Sci"},{"key":"250_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1471-4159.2007.04556.x","volume":"102","author":"P Guidetti","year":"2007","unstructured":"Guidetti P, Amori L, Sapko MT, Okuno E, Schwarcz R. Mitochondrial aspartate aminotransferase: a third kynurenate-producing enzyme in the mammalian brain. J Neurochem. 2007;102:103\u201311.\u00a0","journal-title":"J Neurochem"},{"key":"250_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0361-9230(95)02087-x","volume":"39","author":"HQ Wu","year":"1996","unstructured":"Wu HQ, Schwarcz R. Seizure activity causes elevation of endogenous extracellular kynurenic acid in the rat brain. Brain Res Bull. 1996;39:155\u201362.\u00a0","journal-title":"Brain Res Bull"},{"key":"250_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1471-4159.1988.tb04852.x","volume":"51","author":"F Moroni","year":"1988","unstructured":"Moroni F, Russi P, Lombardi G, Beni M, Carl\u00e0 V. Presence of kynurenic acid in the mammalian brain. J Neurochem. 1988;51:177\u201380.\u00a0","journal-title":"J Neurochem"},{"key":"250_CR33","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1046\/j.0953-816x.2001.01592.x","volume":"13","author":"R Carpenedo","year":"2001","unstructured":"Carpenedo R, Pittaluga A, Cozzi A, Attucci S, Galli A, Raiteri M, et al. Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur J Neurosci. 2001;13:2141\u20137.\u00a0","journal-title":"Eur J Neurosci"},{"key":"250_CR34","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00213-020-05495-y","volume":"237","author":"D Phenis","year":"2020","unstructured":"Phenis D, Vunck SA, Valentini V, Arias H, Schwarcz R, Bruno JP. Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task. Psychopharmacology. 2020;237:1723\u201335.\u00a0","journal-title":"Psychopharmacology"},{"key":"250_CR35","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic diagramming platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53:D1670\u20136.\u00a0","journal-title":"Nucleic Acids Res"},{"key":"250_CR36","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, et al. Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;90:16\u201325.\u00a0","journal-title":"Neurosci Biobehav Rev"},{"key":"250_CR37","doi-asserted-by":"publisher","DOI":"10.1177\/11786469241239125","volume":"17","author":"G Oxenkrug","year":"2024","unstructured":"Oxenkrug G, Forester B. Anthranilic acid, a GPR109A agonist, and schizophrenia. Int J Tryptophan Res. 2024;17:11786469241239125.\u00a0","journal-title":"Int J Tryptophan Res"},{"key":"250_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252413269","volume":"25","author":"G Oxenkrug","year":"2024","unstructured":"Oxenkrug G. Anthranilic acid-G-protein coupled receptor109A-cytosolic phospholipase A2-myelin-cognition cascade: a new target for the treatment\/prevention of cognitive impairment in schizophrenia, dementia, and aging. Int J Mol Sci. 2024;25:13269.\u00a0","journal-title":"Int J Mol Sci"},{"key":"250_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.neuropharm.2016.06.020","volume":"112","author":"F Fazio","year":"2017","unstructured":"Fazio F, Lionetto L, Curto M, Iacovelli L, Copeland CS, Neale SA, et al. Cinnabarinic acid and xanthurenic acid: two kynurenine metabolites that interact with metabotropic glutamate receptors. Neuropharmacology. 2017;112:365\u201372.\u00a0","journal-title":"Neuropharmacology"},{"key":"250_CR40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/antiox8100476","volume":"8","author":"L Kubicova","year":"2019","unstructured":"Kubicova L, Hadacek F, Bachmann G, Weckwerth W, Chobot V. Coordination complex formation and redox properties of kynurenic and xanthurenic acid can affect brain tissue homeodynamics. Antioxidants. 2019;8:476.\u00a0","journal-title":"Antioxidants"},{"key":"250_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115137","volume":"202","author":"G-J Zhou","year":"2022","unstructured":"Zhou G-J, Tang Y-Y, Zuo J-X, Yi T, Tang J-P, Zhang P, et al. Itaconate alleviates \u03b22-microglobulin-induced cognitive impairment by enhancing the hippocampal amino-\u03b2-carboxymuconate-semialdehyde-decarboxylase\/picolinic acid pathway. Biochem Pharmacol. 2022;202:115137.\u00a0","journal-title":"Biochem Pharmacol"},{"key":"250_CR42","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1073\/pnas.0508996103","volume":"103","author":"H Sugimoto","year":"2006","unstructured":"Sugimoto H, Oda S, Otsuki T, Hino T, Yoshida T, Shiro Y. Crystal structure of human indoleamine 2,3-dioxygenase: catalytic mechanism of O2 incorporation by a heme-containing dioxygenase. Proc Natl Acad Sci U S A. 2006;103:2611\u20136.\u00a0","journal-title":"Proc Natl Acad Sci U S A"},{"key":"250_CR43","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.neuro.2021.03.009","volume":"84","author":"RK Sodhi","year":"2021","unstructured":"Sodhi RK, Bansal Y, Singh R, Saroj P, Bhandari R, Kumar B, et al. IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson\u2019s disease. Neurotoxicology. 2021;84:184\u201397.\u00a0","journal-title":"Neurotoxicology"},{"key":"250_CR44","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00787-024-02579-4","volume":"34","author":"S Yang","year":"2025","unstructured":"Yang S, Han J, Ye Z, Zhou H, Yan Y, Han D, et al. The correlation of inflammation, tryptophan-kynurenine pathway, and suicide risk in adolescent depression. Eur Child Adolesc Psychiatry. 2025;34:1557\u201367.\u00a0","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"250_CR45","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/glia.10175","volume":"41","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia. 2003;41:371\u201381.\u00a0","journal-title":"Glia"},{"key":"250_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239333","volume":"21","author":"N Lajk\u00f3","year":"2020","unstructured":"Lajk\u00f3 N, Kata D, Szab\u00f3 M, M\u00e1ty\u00e1s A, Dulka K, F\u00f6ldesi I, et al. Sensitivity of rodent microglia to kynurenines in models of epilepsy and inflammation in vivo and in vitro: microglia activation is inhibited by kynurenic acid and the synthetic analogue SZR104. Int J Mol Sci. 2020;21:9333.\u00a0","journal-title":"Int J Mol Sci"},{"key":"250_CR47","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.eplepsyres.2011.02.003","volume":"94","author":"S Liimatainen","year":"2011","unstructured":"Liimatainen S, Lehtim\u00e4ki K, Raitala A, Peltola M, Oja SS, Peltola J, et al. Increased indoleamine 2,3-dioxygenase (IDO) activity in idiopathic generalized epilepsy. Epilepsy Res. 2011;94:206\u201312.\u00a0","journal-title":"Epilepsy Res"},{"key":"250_CR48","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bbrc.2008.07.156","volume":"375","author":"CFA Vogel","year":"2008","unstructured":"Vogel CFA, Goth SR, Dong B, Pessah IN, Matsumura F. Aryl hydrocarbon receptor signaling mediates expression of indoleamine 2,3-dioxygenase. Biochem Biophys Res Commun. 2008;375:331\u20135.\u00a0","journal-title":"Biochem Biophys Res Commun"},{"key":"250_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/icb.2013.43","volume":"91","author":"CFA Vogel","year":"2013","unstructured":"Vogel CFA, Wu D, Goth SR, Baek J, Lollies A, Domhardt R, et al. Aryl hydrocarbon receptor signaling regulates NF-\u03baB RelB activation during dendritic-cell differentiation. Immunol Cell Biol. 2013;91:568\u201375.","journal-title":"Immunol Cell Biol"},{"key":"250_CR50","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185:3190\u20138.\u00a0","journal-title":"J Immunol"},{"key":"250_CR51","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s11011-023-01267-7","volume":"38","author":"SB Mallik","year":"2023","unstructured":"Mallik SB, Mudgal J, Kinra M, Hall S, Grant GD, Anoopkumar-Dukie S, et al. Involvement of indoleamine 2, 3-dioxygenase (IDO) and brain-derived neurotrophic factor (BDNF) in the neuroprotective mechanisms of ferulic acid against depressive-like behaviour. Metab Brain Dis. 2023;38:2243\u201354.\u00a0","journal-title":"Metab Brain Dis"},{"key":"250_CR52","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3233\/JAD-2011-111097","volume":"28","author":"N Dobos","year":"2012","unstructured":"Dobos N, de Vries EFJ, Kema IP, Patas K, Prins M, Nijholt IM, et al. The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. J Alzheimers Dis. 2012;28:905\u201315.\u00a0","journal-title":"J Alzheimers Dis"},{"key":"250_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2024.114153","volume":"182","author":"IHR de Paiva","year":"2024","unstructured":"de Paiva IHR, Maciel LM, da Silva RS, Mendon\u00e7a IP, de Souza JRB, Peixoto CA. Prebiotics modulate the microbiota-gut-brain axis and ameliorate anxiety and depression-like behavior in HFD-fed mice. Food Res Int. 2024;182:114153.\u00a0","journal-title":"Food Res Int"},{"key":"250_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.993483","volume":"13","author":"R Lu","year":"2022","unstructured":"Lu R, Zhang L, Wang H, Li M, Feng W, Zheng X. Echinacoside exerts antidepressant-like effects through enhancing BDNF-CREB pathway and inhibiting neuroinflammation via regulating microglia M1\/M2 polarization and JAK1\/STAT3 pathway. Front Pharmacol. 2022;13:993483.\u00a0","journal-title":"Front Pharmacol"},{"key":"250_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.vetpar.2019.01.003","volume":"266","author":"LB Jesus","year":"2019","unstructured":"Jesus LB, Santos AB, Jesus EEV, Santos RGD, Grangeiro MS, Bispo-da-Silva A, et al. IDO, COX and iNOS have an important role in the proliferation of Neospora caninum in neuron\/glia co-cultures. Vet Parasitol. 2019;266:96\u2013102.\u00a0","journal-title":"Vet Parasitol"},{"key":"250_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258204","volume":"16","author":"R Ji","year":"2021","unstructured":"Ji R, Ma L, Chen X, Sun R, Zhang L, Saiyin H, et al. Characterizing the distributions of IDO-1 expressing macrophages\/microglia in human and murine brains and evaluating the immunological and physiological roles of IDO-1 in RAW264.7\/BV-2 cells. PLoS One. 2021;16:e0258204.\u00a0","journal-title":"PLoS One"},{"key":"250_CR57","doi-asserted-by":"crossref","unstructured":"Deng N, Hu J, Hong Y, Ding Y, Xiong Y, Wu Z, et al. Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy. Front Cell Neurosci Front Cell Neurosci. 2021;15:638854.","DOI":"10.3389\/fncel.2021.638854"},{"key":"250_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1111\/epi.14675","volume":"60","author":"MB Juda","year":"2019","unstructured":"Juda MB, Brooks AK, Towers AE, Freund GG, McCusker RH, Steelman AJ. Indoleamine 2,3-dioxygenase 1 deletion promotes Theiler\u2019s virus-induced seizures in C57BL\/6J mice. Epilepsia. 2019;60:626\u201335.\u00a0","journal-title":"Epilepsia"},{"key":"250_CR59","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.bbi.2025.07.017","volume":"129","author":"ZA MacDowell Kaswan","year":"2025","unstructured":"MacDowell Kaswan ZA, Brooks AK, Hurtado M, Chen EY, Steelman AJ, McCusker RH. Microglia-specific Ido2 deficiency attenuates ictogenesis in the TMEV model of viral encephalitis. Brain Behav Immun. 2025;129:839\u201356.","journal-title":"Brain Behav Immun"},{"key":"250_CR60","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/1440-1681.13825","volume":"50","author":"R Gupta","year":"2023","unstructured":"Gupta R, Soni D, Upadhayay S, Dhureja M, Kumar P. Impact of noscapine on halting the progression of pentylenetetrazole induced kindling epilepsy in mice. Clin Exp Pharmacol Physiol. 2023;50:984\u201391.\u00a0","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"250_CR61","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0006-8993(93)91612-v","volume":"619","author":"K Nakano","year":"1993","unstructured":"Nakano K, Takahashi S, Mizobuchi M, Kuroda T, Masuda K, Kitoh J. High levels of quinolinic acid in brain of epilepsy-prone E1 mice. Brain Res. 1993;619:195\u20138.\u00a0","journal-title":"Brain Res"},{"key":"250_CR62","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/0920-1211(94)90039-6","volume":"18","author":"CL Eastman","year":"1994","unstructured":"Eastman CL, Urba\u0144ska EM, Chapman AG, Schwarcz R. Differential expression of the astrocytic enzymes 3-hydroxyanthranilic acid oxygenase, kynurenine aminotransferase and glutamine synthetase in seizure-prone and non-epileptic mice. Epilepsy Res. 1994;18:185\u201394.\u00a0","journal-title":"Epilepsy Res"},{"key":"250_CR63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.neures.2006.05.003","volume":"55","author":"M Ganzella","year":"2006","unstructured":"Ganzella M, Jardim FM, Boeck CR, Vendite D. Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice. Neurosci Res. 2006;55:397\u2013402.\u00a0","journal-title":"Neurosci Res"},{"key":"250_CR64","doi-asserted-by":"publisher","first-page":"8538","DOI":"10.1007\/s12035-018-1003-2","volume":"55","author":"FS Ferreira","year":"2018","unstructured":"Ferreira FS, Biasibetti-Brendler H, Pierozan P, Schmitz F, Bert\u00f3 CG, Prezzi CA, et al. Kynurenic acid restores Nrf2 levels and prevents quinolinic acid-induced toxicity in rat striatal slices. Mol Neurobiol. 2018;55:8538\u201349.\u00a0","journal-title":"Mol Neurobiol"},{"key":"250_CR65","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1023\/a:1011119107765","volume":"15","author":"P Heron","year":"2000","unstructured":"Heron P, Daya S. 17Beta-estradiol protects against quinolinic acid-induced lipid peroxidation in the rat brain. Metab Brain Dis. 2000;15:267\u201374.\u00a0","journal-title":"Metab Brain Dis"},{"key":"250_CR66","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.neuroscience.2005.04.056","volume":"134","author":"E Yan","year":"2005","unstructured":"Yan E, Castillo-Mel\u00e9ndez M, Smythe G, Walker D. Quinolinic acid promotes albumin deposition in Purkinje cell, astrocytic activation and lipid peroxidation in fetal brain. Neuroscience. 2005;134:867\u201375.\u00a0","journal-title":"Neuroscience"},{"key":"250_CR67","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/s0006-8993(99)02474-9","volume":"858","author":"E Rodr\u00edguez-Mart\u00ednez","year":"2000","unstructured":"Rodr\u00edguez-Mart\u00ednez E, Camacho A, Maldonado PD, Pedraza-Chaverr\u00ed J, Santamar\u00eda D, Galv\u00e1n-Arzate S, et al. Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum. Brain Res. 2000;858:436\u20139.\u00a0","journal-title":"Brain Res"},{"key":"250_CR68","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2023.13098","volume":"28","author":"Y Gao","year":"2023","unstructured":"Gao Y, Guo X, Zhou Y, Du J, Lu C, Zhang L, et al. Kynurenic acid inhibits macrophage pyroptosis by suppressing ROS production via activation of the NRF2 pathway. Mol Med Rep. 2023;28:211.\u00a0","journal-title":"Mol Med Rep"},{"key":"250_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179428","volume":"25","author":"T Misztal","year":"2024","unstructured":"Misztal T, Roszkowicz-Ostrowska K, Kowalczyk P, M\u0142otkowska P, Marciniak E. Kynurenic acid modulates the expression of genes and the activity of cellular antioxidant enzymes in the hypothalamus and hippocampus in sheep. Int J Mol Sci. 2024;25:9428.\u00a0","journal-title":"Int J Mol Sci"},{"key":"250_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1019365","volume":"13","author":"T Sun","year":"2022","unstructured":"Sun T, Xie R, He H, Xie Q, Zhao X, Kang G, et al. Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35. Front Immunol. 2022;13:1019365.\u00a0","journal-title":"Front Immunol"},{"key":"250_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11010157","volume":"11","author":"ALM Parsons","year":"2022","unstructured":"Parsons ALM, Bucknor EMV, Castroflorio E, Soares TR, Oliver PL, Rial D. The interconnected mechanisms of oxidative stress and neuroinflammation in epilepsy. Antioxidants. 2022;11:157.\u00a0","journal-title":"Antioxidants"},{"key":"250_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.976953","volume":"10","author":"T Fabisiak","year":"2022","unstructured":"Fabisiak T, Patel M. Crosstalk between neuroinflammation and oxidative stress in epilepsy. Front Cell Dev Biol. 2022;10:976953.\u00a0","journal-title":"Front Cell Dev Biol"},{"key":"250_CR73","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1111\/bph.15534","volume":"178","author":"S Dey","year":"2021","unstructured":"Dey S, Banerjee Dixit A, Tripathi M, Doddamani RS, Sharma MC, Lalwani S, et al. Altered hippocampal kynurenine pathway metabolism contributes to hyperexcitability in human mesial temporal lobe epilepsy-hippocampal sclerosis. Br J Pharmacol. 2021;178:3959\u201376.\u00a0","journal-title":"Br J Pharmacol"},{"key":"250_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cells11223560","volume":"11","author":"S Dey","year":"2022","unstructured":"Dey S, Dubey V, Dixit AB, Tripathi M, Chandra PS, Banerjee J. Differential levels of tryptophan-kynurenine pathway metabolites in the hippocampus, anterior temporal lobe, and neocortex in an animal model of temporal lobe epilepsy. Cells. 2022;11:3560.\u00a0","journal-title":"Cells"},{"key":"250_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2024.115070","volume":"384","author":"Y Wang","year":"2025","unstructured":"Wang Y, Wu W, Zeng F, Meng X, Peng M, Wang J, et al. The role of kynurenine pathway metabolism mediated by exercise in the microbial-gut-brain axis in Alzheimer\u2019s disease. Exp Neurol. 2025;384:115070.\u00a0","journal-title":"Exp Neurol"},{"key":"250_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082180","volume":"8","author":"R Berlinguer-Palmini","year":"2013","unstructured":"Berlinguer-Palmini R, Masi A, Narducci R, Cavone L, Maratea D, Cozzi A, et al. GPR35 activation reduces Ca2+ transients and contributes to the kynurenic acid-dependent reduction of synaptic activity at CA3-CA1 synapses. PLoS ONE. 2013;8:e82180.\u00a0","journal-title":"PLoS ONE"},{"key":"250_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-6-36","volume":"6","author":"KK Ting","year":"2009","unstructured":"Ting KK, Brew BJ, Guillemin GJ. Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer\u2019s disease. J Neuroinflammation. 2009;6:36.\u00a0","journal-title":"J Neuroinflammation"},{"key":"250_CR78","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1067\/mob.2001.108862","volume":"184","author":"T Nicholls","year":"2001","unstructured":"Nicholls T, Lacey B, Nitsos I, Smythe G, Walker DW. Regional changes in kynurenic acid, quinolinic acid, and glial fibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiency. Am J Obstet Gynecol. 2001;184:203\u20138.\u00a0","journal-title":"Am J Obstet Gynecol"},{"key":"250_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2019.108884","volume":"315","author":"S Esmaeili","year":"2020","unstructured":"Esmaeili S, Ghobadi N, Akbari V, Moradi S, Shahlaie M, Ghobadi S, et al. Pyridine-2,3-dicarboxylate, quinolinic acid, induces 1N4R Tau amyloid aggregation in vitro: another evidence for the detrimental effect of the inescapable endogenous neurotoxin. Chem Biol Interact. 2020;315:108884.\u00a0","journal-title":"Chem Biol Interact"},{"key":"250_CR80","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000982","volume":"8","author":"N Joisten","year":"2021","unstructured":"Joisten N, Rademacher A, Warnke C, Proschinger S, Schenk A, Walzik D, et al. Exercise diminishes plasma neurofilament light chain and reroutes the kynurenine pathway in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021;8:e982.\u00a0","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"250_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-016-0143-y","volume":"12","author":"Y Wang","year":"2017","unstructured":"Wang Y, Balaji V, Kaniyappan S, Kr\u00fcger L, Irsen S, Tepper K, et al. The release and trans-synaptic transmission of Tau via exosomes. Mol Neurodegener. 2017;12:5.","journal-title":"Mol Neurodegener"},{"key":"250_CR82","doi-asserted-by":"publisher","first-page":"12224","DOI":"10.3390\/ijms232012224","volume":"23","author":"AV Griflyuk","year":"2022","unstructured":"Griflyuk AV, Postnikova TY, Zaitsev AV. Prolonged febrile seizures impair synaptic plasticity and alter developmental pattern of glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes in the hippocampus of young rats. Int J Mol Sci. 2022;23:12224.\u00a0","journal-title":"Int J Mol Sci"},{"key":"250_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2025.110362","volume":"269","author":"M Xu","year":"2025","unstructured":"Xu M, Wang J, Shi J, Wu X, Zhao Q, Shen H, et al. Esketamine mitigates endotoxin-induced hippocampal injury by regulating calcium transient and synaptic plasticity via the NF-\u03b11\/CREB pathway. Neuropharmacology. 2025;269:110362.\u00a0","journal-title":"Neuropharmacology"},{"key":"250_CR84","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/mp.2012.77","volume":"18","author":"G Clarke","year":"2013","unstructured":"Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry. 2013;18:666\u201373.\u00a0","journal-title":"Mol Psychiatry"},{"key":"250_CR85","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jpsychires.2008.03.009","volume":"43","author":"L Desbonnet","year":"2008","unstructured":"Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG. The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res. 2008;43:164\u201374.\u00a0","journal-title":"J Psychiatr Res"},{"key":"250_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02838","volume":"9","author":"C Martin-Gallausiaux","year":"2018","unstructured":"Martin-Gallausiaux C, Larraufie P, Jarry A, B\u00e9guet-Crespel F, Marinelli L, Ledue F, et al. Butyrate produced by commensal bacteria down-regulates indolamine 2,3-dioxygenase 1 (IDO-1) expression via a dual mechanism in human intestinal epithelial cells. Front Immunol. 2018;9:2838.\u00a0","journal-title":"Front Immunol"},{"key":"250_CR87","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.apsb.2020.07.017","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Li D, Zhang Y, Chen J, Zhang Y, Liao C, et al. Functional metabolomics reveal the role of AHR\/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage. Acta Pharm Sin B. 2021;11:763\u201380.\u00a0","journal-title":"Acta Pharm Sin B"},{"key":"250_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02262-4","volume":"18","author":"SE Barnes","year":"2021","unstructured":"Barnes SE, Zera KA, Ivison GT, Buckwalter MS, Engleman EG. Brain profiling in murine colitis and human epilepsy reveals neutrophils and TNF\u03b1 as mediators of neuronal hyperexcitability. J Neuroinflammation. 2021;18:199.\u00a0","journal-title":"J Neuroinflammation"},{"key":"250_CR89","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbi.2024.04.007","volume":"119","author":"V Kebede","year":"2024","unstructured":"Kebede V, Ravizza T, Balosso S, Di Sapia R, Canali L, Soldi S, et al. Early treatment with rifaximin during epileptogenesis reverses gut alterations and reduces seizure duration in a mouse model of acquired epilepsy. Brain Behav Immun. 2024;119:363\u201380.\u00a0","journal-title":"Brain Behav Immun"},{"key":"250_CR90","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","volume":"44","author":"TW Stone","year":"2023","unstructured":"Stone TW, Williams RO. Modulation of T cells by tryptophan metabolites in the kynurenine pathway. Trends Pharmacol Sci. 2023;44:442\u201356.\u00a0","journal-title":"Trends Pharmacol Sci"},{"key":"250_CR91","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1179456","volume":"14","author":"Y Okamoto","year":"2023","unstructured":"Okamoto Y, Shikano S. Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology. Front Immunol. 2023;14:1179456.\u00a0","journal-title":"Front Immunol"},{"key":"250_CR92","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.bbi.2024.06.027","volume":"121","author":"J Spielbauer","year":"2024","unstructured":"Spielbauer J, Glotfelty EJ, Sarlus H, Harris RA, Diaz Heijtz R, Karlsson TE. Bacterial peptidoglycan signalling in microglia: activation by MDP via the NF-\u03baB\/MAPK pathway. Brain Behav Immun. 2024;121:43\u201355.\u00a0","journal-title":"Brain Behav Immun"},{"key":"250_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2025.117972","volume":"292","author":"Y Lin","year":"2025","unstructured":"Lin Y, Lang H, Gao P, Miao X, Guo Q, Hao Y, et al. Electromagnetic pulse exposure induces neuroinflammation and blood-brain barrier disruption by activating the NLRP3 inflammasome\/NF-\u03baB signaling pathway in mice. Ecotoxicol Environ Saf. 2025;292:117972.\u00a0","journal-title":"Ecotoxicol Environ Saf"},{"key":"250_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105742","volume":"116","author":"V Bucher","year":"2025","unstructured":"Bucher V, Herrock OT, Schell S, Visser J, Imberg H, Burke J, et al. Blood-brain barrier injury and neuroinflammation in pre-eclampsia and eclampsia. EBioMedicine. 2025;116:105742.\u00a0","journal-title":"EBioMedicine"},{"key":"250_CR95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.molmet.2018.03.016","volume":"12","author":"KL Egerod","year":"2018","unstructured":"Egerod KL, Petersen N, Timshel PN, Rekling JC, Wang Y, Liu Q, et al. Profiling of G protein-coupled receptors in vagal afferents reveals novel gut-to-brain sensing mechanisms. Mol Metab. 2018;12:62\u201375.\u00a0","journal-title":"Mol Metab"},{"key":"250_CR96","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.brainresbull.2020.07.023","volume":"163","author":"J Zhu","year":"2020","unstructured":"Zhu J, Xu C, Zhang X, Qiao L, Wang X, Yan X, et al. The effect of vagal nerve stimulation on hippocampal-thalamic functional connectivity in epilepsy patients. Brain Res Bull. 2020;163:143\u20139.\u00a0","journal-title":"Brain Res Bull"},{"key":"250_CR97","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0165-1838(83)90129-7","volume":"9","author":"PE Sawchenko","year":"1983","unstructured":"Sawchenko PE. Central connections of the sensory and motor nuclei of the vagus nerve. J Auton Nerv Syst. 1983;9:13\u201326.\u00a0","journal-title":"J Auton Nerv Syst"},{"key":"250_CR98","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cns.13449","volume":"27","author":"J Zhu","year":"2021","unstructured":"Zhu J, Xu C, Zhang X, Qiao L, Wang X, Zhang X, et al. Altered amplitude of low-frequency fluctuations and regional homogeneity in drug-resistant epilepsy patients with vagal nerve stimulators under different current intensity. CNS Neurosci Ther. 2021;27:320\u20139.\u00a0","journal-title":"CNS Neurosci Ther"},{"key":"250_CR99","doi-asserted-by":"publisher","DOI":"10.34133\/research.0846","volume":"8","author":"T Meng","year":"2025","unstructured":"Meng T, Zhang Y, Fu S, Ma S. Gpr35 expression mitigates neuroinflammation and enriches gut Lactobacillus to relieve Parkinson\u2019s disease. Research. 2025;8:0846.\u00a0","journal-title":"Research"},{"key":"250_CR100","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1039\/d1fo03334d","volume":"13","author":"Y Xi","year":"2022","unstructured":"Xi Y, Li H, Yu M, Li X, Li Y, Hui B, et al. Protective effects of chlorogenic acid on trimethyltin chloride-induced neurobehavioral dysfunctions in mice relying on the gut microbiota. Food Funct. 2022;13:1535\u201350.\u00a0","journal-title":"Food Funct"},{"key":"250_CR101","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.seizure.2019.05.006","volume":"69","author":"I \u017barnowska","year":"2019","unstructured":"\u017barnowska I, Wr\u00f3bel-Dudzi\u0144ska D, Tulidowicz-Bielak M, Kocki T, Mitosek-Szewczyk K, Gasior M, et al. Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy. Seizure. 2019;69:265\u201372.\u00a0","journal-title":"Seizure"},{"key":"250_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104280","volume":"84","author":"J Yan","year":"2022","unstructured":"Yan J, Kothur K, Innes EA, Han VX, Jones HF, Patel S, et al. Decreased cerebrospinal fluid kynurenic acid in epileptic spasms: a biomarker of response to corticosteroids. EBioMedicine. 2022;84:104280.\u00a0","journal-title":"EBioMedicine"},{"key":"250_CR103","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/epi.17899","volume":"65","author":"A Hanin","year":"2024","unstructured":"Hanin A, Chollet C, Demeret S, Di Meglio L, Castelli F, Navarro V. Metabolomic changes in adults with status epilepticus: a human case-control study. Epilepsia. 2024;65:929\u201343.\u00a0","journal-title":"Epilepsia"},{"key":"250_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2023.104589","volume":"91","author":"J Yan","year":"2023","unstructured":"Yan J, Kothur K, Mohammad S, Chung J, Patel S, Jones HF, et al. CSF neopterin, quinolinic acid and kynurenine\/tryptophan ratio are biomarkers of active neuroinflammation. EBioMedicine. 2023;91:104589.\u00a0","journal-title":"EBioMedicine"},{"key":"250_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1109469","volume":"14","author":"Y Peng","year":"2023","unstructured":"Peng Y, Chiu ATG, Li VWY, Zhang X, Yeung WL, Chan SHS, et al. The role of the gut-microbiome-brain axis in metabolic remodeling amongst children with cerebral palsy and epilepsy. Front Neurol. 2023;14:1109469.\u00a0","journal-title":"Front Neurol"},{"key":"250_CR106","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1159\/000315530","volume":"18","author":"HJM Majoie","year":"2011","unstructured":"Majoie HJM, Rijkers K, Berfelo MW, Hulsman J, Myint A, Schwarz M, et al. Vagus nerve stimulation in refractory epilepsy: effects on pro- and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation. 2011;18:52\u20136.\u00a0","journal-title":"Neuroimmunomodulation"},{"key":"250_CR107","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14398","volume":"30","author":"L Wan","year":"2024","unstructured":"Wan L, Shi X, Yan H, Liang Y, Liu X, Zhu G, et al. Abnormalities in Clostridioides and related metabolites before ACTH treatment may be associated with its efficacy in patients with infantile epileptic spasm syndrome. CNS Neurosci Ther. 2024;30:e14398.\u00a0","journal-title":"CNS Neurosci Ther"},{"key":"250_CR108","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.yebeh.2014.06.001","volume":"37","author":"S Klinkenberg","year":"2014","unstructured":"Klinkenberg S, van den Borne CJH, Aalbers MW, Verschuure P, Kessels AG, Leenen L, et al. The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy. Epilepsy Behav. 2014;37:133\u20138.\u00a0","journal-title":"Epilepsy Behav"},{"key":"250_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2025.115142","volume":"385","author":"C-M Qiao","year":"2025","unstructured":"Qiao CM, Ma XY, Tan LL, Xia YM, Li T, Wu J, et al. Indoleamine 2, 3-dioxygenase 1 inhibition mediates the therapeutic effects in Parkinson\u2019s disease mice by modulating inflammation and neurogenesis in a gut microbiota dependent manner. Exp Neurol. 2025;385:115142.\u00a0","journal-title":"Exp Neurol"},{"key":"250_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115216","volume":"406","author":"AG Aslamkhan","year":"2020","unstructured":"Aslamkhan AG, Xu Q, Loughlin A, Vu H, Pacchione S, Bhatt B, et al. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1\/Tdo2 knockout mice. Toxicol Appl Pharmacol. 2020;406:115216.\u00a0","journal-title":"Toxicol Appl Pharmacol"},{"key":"250_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.149246","volume":"1846","author":"N Samriti","year":"2025","unstructured":"Samriti N, Kaur A, Kaur A, Goel RK. Ameliorative effect of diclofenac in rotenone corneal kindling model of drug-resistant epilepsy: edge of dual COX and KMO inhibition. Brain Res. 2025;1846:149246.","journal-title":"Brain Res"},{"key":"250_CR112","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3390\/cimb47090705","volume":"47","author":"J Xu","year":"2025","unstructured":"Xu J, Huang Y, Wei L, Kong Z, Fu J, Cai L. Kmo inhibition improves seizures and depressive-like behaviors without aggravating cognitive impairment in epileptic mice. Curr Issues Mol Biol. 2025;47:705.","journal-title":"Curr Issues Mol Biol"},{"key":"250_CR113","doi-asserted-by":"publisher","first-page":"E274","DOI":"10.1152\/ajpendo.00386.2024","volume":"328","author":"KD Dumont","year":"2025","unstructured":"Dumont KD, Jannig PR, Porsmyr-Palmertz M, Ruas JL. Constitutive loss of kynurenine-3-monooxygenase changes circulating kynurenine metabolites without affecting systemic energy metabolism. Am J Physiol Endocrinol Metab. 2025;328:E274-85.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"250_CR114","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009129","volume":"16","author":"DC Maddison","year":"2020","unstructured":"Maddison DC, Alfonso-N\u00fa\u00f1ez M, Swaih AM, Breda C, Campesan S, Allcock N, et al. A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics. PLoS Genet. 2020;16:e1009129.","journal-title":"PLoS Genet"},{"key":"250_CR115","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s12640-017-9836-4","volume":"33","author":"M Dircio-Bautista","year":"2018","unstructured":"Dircio-Bautista M, Col\u00edn-Gonz\u00e1lez AL, Aguilera G, Maya-L\u00f3pez M, Villeda-Hern\u00e1ndez J, Galv\u00e1n-Arzate S, et al. The antiepileptic drug levetiracetam protects against quinolinic acid-induced toxicity in the rat striatum. Neurotox Res. 2018;33:837\u201345.\u00a0","journal-title":"Neurotox Res"},{"key":"250_CR116","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1111\/bph.14491","volume":"175","author":"K Fukuyama","year":"2018","unstructured":"Fukuyama K, Okada M. Effects of levetiracetam on astroglial release of kynurenine-pathway metabolites. Br J Pharmacol. 2018;175:4253\u201365.\u00a0","journal-title":"Br J Pharmacol"},{"key":"250_CR117","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1124\/mol.111.074765","volume":"81","author":"F Fazio","year":"2012","unstructured":"Fazio F, Lionetto L, Molinaro G, Bertrand HO, Acher F, Ngomba RT, et al. Cinnabarinic acid, an endogenous metabolite of the kynurenine pathway, activates type 4 metabotropic glutamate receptors. Mol Pharmacol. 2012;81:643\u201356.\u00a0","journal-title":"Mol Pharmacol"},{"key":"250_CR118","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.neuropharm.2007.10.004","volume":"54","author":"RT Ngomba","year":"2008","unstructured":"Ngomba RT, Ferraguti F, Badura A, Citraro R, Santolini I, Battaglia G, et al. Positive allosteric modulation of metabotropic glutamate 4 (mGlu4) receptors enhances spontaneous and evoked absence seizures. Neuropharmacology. 2008;54:344\u201354.\u00a0","journal-title":"Neuropharmacology"},{"key":"250_CR119","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuint.2016.12.023","volume":"104","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK. Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression. Neurochem Int. 2017;104:27\u201333.\u00a0","journal-title":"Neurochem Int"},{"key":"250_CR120","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1007\/s11064-017-2325-6","volume":"42","author":"T Singh","year":"2017","unstructured":"Singh T, Kaur T, Goel RK. Ferulic acid supplementation for management of depression in epilepsy. Neurochem Res. 2017;42:2940\u20138.\u00a0","journal-title":"Neurochem Res"},{"key":"250_CR121","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejphar.2004.07.088","volume":"498","author":"T Kocki","year":"2004","unstructured":"Kocki T, Kocki J, Wielosz M, Turski WA, Urbanska EM. Carbamazepine enhances brain production of kynurenic acid in vitro. Eur J Pharmacol. 2004;498:325\u20136.\u00a0","journal-title":"Eur J Pharmacol"},{"key":"250_CR122","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2006.05.015","volume":"541","author":"T Kocki","year":"2006","unstructured":"Kocki T, Wielosz M, Turski WA, Urbanska EM. Enhancement of brain kynurenic acid production by anticonvulsants\u2013novel mechanism of antiepileptic activity? Eur J Pharmacol. 2006;541:147\u201351.\u00a0","journal-title":"Eur J Pharmacol"},{"key":"250_CR123","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.nbd.2012.03.010","volume":"46","author":"C Ghosh","year":"2012","unstructured":"Ghosh C, Marchi N, Hossain M, Rasmussen P, Alexopoulos AV, Gonzalez-Martinez J, et al. A pro-convulsive carbamazepine metabolite: quinolinic acid in drug resistant epileptic human brain. Neurobiol Dis. 2012;46:692\u2013700.\u00a0","journal-title":"Neurobiol Dis"},{"key":"250_CR124","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0006-8993(88)90829-3","volume":"454","author":"A Vezzani","year":"1988","unstructured":"Vezzani A, Wu HQ, Angelico P, Stasi MA, Samanin R. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis. Brain Res. 1988;454:289\u201397.\u00a0","journal-title":"Brain Res"},{"key":"250_CR125","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0022-3565(25)23905-2","volume":"239","author":"A Vezzani","year":"1986","unstructured":"Vezzani A, Wu HQ, Tullii M, Samanin R. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments. J Pharmacol Exp Ther. 1986;239:256\u201363.","journal-title":"J Pharmacol Exp Ther"},{"key":"250_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2023.107246","volume":"198","author":"A Kaur","year":"2023","unstructured":"Kaur A, Kumar S, Goel RK. Adjunct antiseizure effect of clotrimazole in a rotenone corneal kindling mouse model of mitochondrial drug-resistant epilepsy. Epilepsy Res. 2023;198:107246.\u00a0","journal-title":"Epilepsy Res"},{"key":"250_CR127","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.yebeh.2016.05.005","volume":"61","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK. Evidence in support of using a neurochemistry approach to identify therapy for both epilepsy and associated depression. Epilepsy Behav. 2016;61:248\u201357.\u00a0","journal-title":"Epilepsy Behav"},{"key":"250_CR128","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-11-41","volume":"11","author":"W Xie","year":"2014","unstructured":"Xie W, Cai L, Yu Y, Gao L, Xiao L, He Q, et al. Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy. J Neuroinflammation. 2014;11:41.\u00a0","journal-title":"J Neuroinflammation"},{"key":"250_CR129","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejphar.2016.05.019","volume":"784","author":"T Singh","year":"2016","unstructured":"Singh T, Goel RK. Adjuvant indoleamine 2,3-dioxygenase enzyme inhibition for comprehensive management of epilepsy and comorbid depression. Eur J Pharmacol. 2016;784:111\u201320.\u00a0","journal-title":"Eur J Pharmacol"},{"key":"250_CR130","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.biopha.2017.05.085","volume":"92","author":"T Singh","year":"2017","unstructured":"Singh T, Bagga N, Kaur A, Kaur N, Gawande DY, Goel RK. Agmatine for combined treatment of epilepsy, depression and cognitive impairment in chronic epileptic animals. Biomed Pharmacother. 2017;92:720\u20135.\u00a0","journal-title":"Biomed Pharmacother"},{"key":"250_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.108262","volume":"123","author":"S Agarwal","year":"2021","unstructured":"Agarwal S, Vyas P, Nirwan N, Vohora D. Effect of lacosamide on neuroinflammation-mediated seizures comorbid with depression in C57BL\/6 mice- role of kynurenine pathway. Epilepsy & Behavior: E&B. 2021;123:108262.\u00a0","journal-title":"Epilepsy & Behavior: E&B"}],"container-title":["Acta Epileptologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42494-026-00250-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42494-026-00250-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:04:51Z","timestamp":1777590291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42494-026-00250-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":131,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["250"],"URL":"https:\/\/doi.org\/10.1186\/s42494-026-00250-w","relation":{},"ISSN":["2096-9384","2524-4434"],"issn-type":[{"value":"2096-9384","type":"print"},{"value":"2524-4434","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}